HROW - Harrow Health, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
49,945
41,372
26,774
19,942
Cost of Revenue
17,286
16,521
13,505
9,831
Gross Profit
32,659
24,851
13,269
10,111
Operating Expenses
Research Development
2,092
825
413
739
Selling General and Administrative
34,411
29,243
25,019
24,951
Total Operating Expenses
36,503
30,068
25,432
25,690
Operating Income or Loss
-3,844
-5,217
-12,163
-15,579
Interest Expense
-
-
-
-
Total Other Income/Expenses Net
21,885
22,570
2,269
-845
Income Before Tax
15,413
14,625
-12,920
-19,198
Income Tax Expense
0
0
-935
-111
Income from Continuing Operations
15,413
14,625
-11,985
-19,087
Net Income
15,641
14,625
-11,985
-19,087
Net Income available to common shareholders
15,641
14,625
-11,985
-19,087
Reported EPS
Basic
-
0.67
-0.60
-1.50
Diluted
-
0.61
-0.60
-1.50
Weighted average shares outstanding
Basic
-
21,918
20,028
12,743
Diluted
-
23,812
20,028
12,743
EBITDA
-
-3,374
-10,398
-14,173